Analysis Ambar Protein Industries Limit (AMBARPIL)
5/27/2024
Analysis of Ambar Protein Industries Limit (AMBARPIL)
Ambar Protein Industries Limited has been showing some fluctuations in its stock price recently. The Relative Strength Index (RSI) values have been hovering around the 50 mark, indicating a neutral trend. The Moving Average Convergence Divergence (MACD) indicator has been mostly negative, suggesting a bearish momentum.The stock price has been moving around the 160 mark, with some volatility in the recent days. The Simple Moving Average (SMA) and Exponential Moving Average (EMA) are close to the current price, indicating a possible consolidation phase.
Overall, the stock seems to be in a consolidation phase with no clear trend direction. Traders and investors may need to wait for a clearer signal before making any significant trading decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating good financial performance. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows a solid return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows the stock's performance over the past year, with details on moving averages, 52-week high and low, and beta.
Valuation metrics reveal the company's price-to-earnings ratios, enterprise value, price-to-book ratio, price-to-sales ratio, and market capitalization. The PEG ratio suggests potential overvaluation.
Lastly, dividends and splits information includes details on dividend rates, payout ratios, dividend dates, and historical split data. The company offers a forward annual dividend yield and has a 5-year average dividend yield.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to achieve an average annual growth rate of 11%.
- However, when looking at the past 5 years, the company has actually achieved a higher average annual growth rate of approximately 20.1%.
Overall, the company is expected to maintain a solid growth trajectory, with a slightly lower growth rate in the short term compared to the long-term average.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it can be observed that the analysts have a range of opinions regarding the future price of the security, with the majority clustering around the median and average values. The current price is below both the median and average forecast, indicating a potential upside according to the analysts' predictions.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe the following trends:
1. There was a steady increase in revenue from 2020 to 2022, with a slight decrease in 2023.
2. The company experienced significant growth in revenue between 2020 and 2022, indicating positive performance.
3. The slight decrease in revenue in 2023 could be a result of various factors such as market conditions, competition, or internal changes within the company.
4. Overall, the company has shown resilience and growth in its revenue over the past four years, despite the slight dip in 2023.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:1. The total assets have been increasing over the years, indicating growth in the company's overall value.
2. Current assets have fluctuated, with some years showing higher cash reserves and others showing higher inventory levels.
3. Non-current assets have generally increased, with investments and advances being a significant portion of the assets.
4. Total liabilities have also been on the rise, but at a slower pace compared to total assets.
5. Shareholders' equity has shown variations, influenced by factors such as common stock, retained earnings, and other equity components.
6. The company seems to be managing its short-term and long-term debts effectively, as the liabilities are not growing at a faster rate than assets.
7. The company has been investing in non-current assets like machinery, furniture, and equipment, which indicates a focus on long-term growth and sustainability.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, compared to $1.26 a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 a year ago.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, compared to $6.13 a year ago.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, compared to $6.59 a year ago.
Overall, analysts are forecasting an increase in earnings per share for both the current and next fiscal years, indicating positive growth expectations for the company.
MACD of AMBARPIL
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
